![]() |
|
|


* Department of Molecular Biosciences and
Department of Anatomy, Physiology, and Cell Biology, School of Veterinary Medicine, University of California, Davis, CA
3 To whom correspondence should be addressed. E-mail: crestorres{at}hotmail.com.
KEY WORDS: taurine dog platelet function whole blood taurine
Clot formation is a protective mechanism that animals have evolved to minimize blood loss when a vessel has been disrupted. The actual clotting formation is a complex signaling reaction in which a multitude of factors are involved. Blood taurine concentration has been suggested as a modulating factor in the clotting cascade. Upon taurine depletion in cats, platelet taurine concentration decreases, and as a result, the rate of ex vivo aggregation increases (1). In human blood, ex vivo taurine supplementation increases the resistance to platelet aggregation, the latter being correlated with decreased thromboxane release during aggregation. To the authors' knowledge, there are no studies that determine whether a similar enhancement of clot formation occurs in taurine deficient dogs. This study was designed to determine whether taurine depletion in dogs affects platelet taurine concentration and function.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Fifteen milliliters of blood were collected from 6 taurine-sufficient dogs (Tau+) and 7 taurine-deficient dogs (Tau). Dogs with blood taurine concentrations <180 nmol/mL were considered taurine deficient. Blood cell counts and platelet counts were performed using automated standard procedures. Taurine concentrations for whole blood and platelets were done using procedures previously described (3). Three dogs were excluded from analyses because of sample handling problems.
Platelets, platelet rich plasma (PRP) and platelet poor plasma (PPP) separations were done using a modification of the protocol by Field et al. (4). Sodium citrate was used as the anticoagulant agent. PRP and PPP were harvested after consecutive centrifugations at 312.5 x g for 20 min and 1800 x g for 10 min, respectively. Platelet pellets were resuspended with 6% dextran in sterile saline at 37°C. Ex vivo platelet function was measured by optical aggregometry (OA) and whole blood electric impedance aggregometry (WBEI) using collagen as a platelet agonist. Results were analyzed using Student's t test to estimate difference between groups (Systat 9, SPSS). P
0.05 was taken as an indication of statistical differences and a P > 0.05 < 0.10 was taken as a trend. Values reported in the text are means ± SEM.
| RESULTS |
|---|
|
|
|---|
|
|
|
|
| DISCUSSION |
|---|
|
|
|---|
Platelets from taurine-deficient cats and humans are more sensitive to clotting stimulus than their taurine-sufficient counterparts (1). In the present study, platelet function was measured by 2 different assays. We found that the proportion of aggregation and speed of aggregation between Tau+ and Tau groups of adult dogs did not differ. Nevertheless, there are a few points to take into consideration in interpreting these findings. Although the difference between the groups was significant, whole blood taurine concentrations of individuals in the Tau group were not severely depleted compared with cats or humans from other studies (1). It is possible that if the animals were in a greater stage of taurine depletion, the platelet results could have shown differences. Also, the range of whole blood and platelet taurine concentration was very broad, and therefore the variation was large. The variances within sample especially in the Tau+ group may have affected the ability of finding differences, when they exist. If not, the results show a difference in the role of taurine as it affects clotting among dogs vs. cats and humans.
Taurine deficient platelets do not seem to be hyper-reactive in dogs with mild taurine deficiency. Further studies with a larger number of dogs with more severe taurine deficiency are needed to determine whether there is a difference in aggregation function between taurine deficient vs. clinically normal dogs.
| FOOTNOTES |
|---|
2 Author disclosure: no relationships to disclose. ![]()
| LITERATURE CITED |
|---|
|
|
|---|
1. Hayes KC, Pronczuk A, Addesa AE, Stephan ZF. Taurine modulates platelet aggregation in cats and humans. Am J Clin Nutr. 1989;49:12116.
2. National Reserch Council. Guide for the care and use of laboratory animals. Washington: National Academy Press, 1996.
3. Tôrres CL, Backus RC, Fascetti AJ, Rogers QR. Taurine status in normal dogs fed a commercial diet associated with taurine deficiency and dilated cardiomyopathy. J Anim Physiol Anim Nutr (Berl). 2003;87:35972.[Medline]
4. Field CL, Walker NJ, Tablin F. Northern elephant seal platelets: analysis of shape change and response to platelet agonists. Thromb Res. 2001;101:26777.[Medline]
5. Delaney SJ, Kass PH, Rogers QR, Fascetti AJ. Plasma and blood taurine in normal dogs of varying size fed commercially prepared food. J Anim Physiol Anim Nutr (Berl). 2003;87:23644.[Medline]
6. Laidlaw SA, Sturman JA, Kopple JD. Effect of dietary taurine on plasma and blood cell taurine concentrations in cats. J Nutr. 1987;117:194559.
7. Vinton NE, Laidlaw SA, Ament ME, Kopple JD. Taurine concentrations in plasma and blood cells of patients undergoing long-term parenteral nutrition. Am J Clin Nutr. 1986;44:398404.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||